0000905718-15-000774.txt : 20150914
0000905718-15-000774.hdr.sgml : 20150914
20150914082139
ACCESSION NUMBER: 0000905718-15-000774
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150911
FILED AS OF DATE: 20150914
DATE AS OF CHANGE: 20150914
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-200-7500
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CATLIN AVERY W
CENTRAL INDEX KEY: 0001255348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 151104707
MAIL ADDRESS:
STREET 1: 241 CENTRAL STREET
CITY: HINGHAM
STATE: MA
ZIP: 02043
4
1
avery_form4sept112015.xml
OWNERSHIP DOCUMENT
X0306
4
2015-09-11
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001255348
CATLIN AVERY W
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD
HAMPTON
NJ
08827
0
1
0
0
Sr. VP & CFO
Common Stock, par value $0.001 per share
2015-09-11
4
M
0
10000
4.5
A
35109
D
Incentive Stock Option
4.5
2015-09-11
4
M
0
10000
0
D
2013-01-21
2020-01-21
Common Stock
10000
7847
D
Includes 500 shares of common stock acquired under the Company's 2004 Employee Stock Purchase Plan on June 30, 2015.
As of January 21, 2014, the option was fully vested.
/s/ Anthony S. Marucci, attorney in fact for Avery W. Catlin
2015-09-11